Scolyer RA - Search Results

1

A sheep in wolf's clothing: Agminated blue naevi masquerading as in-transit melanoma metastases.

Allen NC, Paver EC, Agar N, Scolyer RA, Moloney FJ. Allen NC, et al. Among authors: scolyer ra. Australas J Dermatol. 2023 May;64(2):e196-e199. doi: 10.1111/ajd.14002. Epub 2023 Feb 25. Australas J Dermatol. 2023. PMID: 36840895 Free PMC article. No abstract available.

2

BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.

Bock VL, Lyons JG, Huang XX, Jones AM, McDonald LA, Scolyer RA, Moloney FJ, Barnetson RS, Halliday GM. Bock VL, et al. Among authors: scolyer ra. Br J Dermatol. 2011 Jun;164(6):1221-7. doi: 10.1111/j.1365-2133.2011.10267.x. Epub 2011 May 13. Br J Dermatol. 2011. PMID: 21564052

3

Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy.

Guitera P, Moloney FJ, Menzies SW, Stretch JR, Quinn MJ, Hong A, Fogarty G, Scolyer RA. Guitera P, et al. Among authors: scolyer ra. JAMA Dermatol. 2013 Jun;149(6):692-8. doi: 10.1001/jamadermatol.2013.2301. JAMA Dermatol. 2013. PMID: 23553208

4

Dermoscopic evaluation of nodular melanoma.

Menzies SW, Moloney FJ, Byth K, Avramidis M, Argenziano G, Zalaudek I, Braun RP, Malvehy J, Puig S, Rabinovitz HS, Oliviero M, Cabo H, Bono R, Pizzichetta MA, Claeson M, Gaffney DC, Soyer HP, Stanganelli I, Scolyer RA, Guitera P, Kelly J, McCurdy O, Llambrich A, Marghoob AA, Zaballos P, Kirchesch HM, Piccolo D, Bowling J, Thomas L, Terstappen K, Tanaka M, Pellacani G, Pagnanelli G, Ghigliotti G, Ortega BC, Crafter G, Ortiz AM, Tromme I, Karaarslan IK, Ozdemir F, Tam A, Landi C, Norton P, Kaçar N, Rudnicka L, Slowinska M, Simionescu O, Di Stefani A, Coates E, Kreusch J. Menzies SW, et al. Among authors: scolyer ra. JAMA Dermatol. 2013 Jun;149(6):699-709. doi: 10.1001/jamadermatol.2013.2466. JAMA Dermatol. 2013. PMID: 23553375 Free article.

5

Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).

Cho EA, Moloney FJ, Cai H, Au-Yeung A, China C, Scolyer RA, Yosufi B, Raftery MJ, Deng JZ, Morton SW, Hammond PT, Arkenau HT, Damian DL, Francis DJ, Chesterman CN, Barnetson RS, Halliday GM, Khachigian LM. Cho EA, et al. Among authors: scolyer ra. Lancet. 2013 May 25;381(9880):1835-43. doi: 10.1016/S0140-6736(12)62166-7. Epub 2013 May 7. Lancet. 2013. PMID: 23660123 Free PMC article. Clinical Trial.

6

Punch biopsy of melanoma causing tumour cell implantation: another peril of utilising partial biopsies for melanocytic tumours.

Luk PP, Vilain R, Crainic O, McCarthy SW, Thompson JF, Scolyer RA. Luk PP, et al. Among authors: scolyer ra. Australas J Dermatol. 2015 Aug;56(3):227-31. doi: 10.1111/ajd.12333. Epub 2015 Mar 31. Australas J Dermatol. 2015. PMID: 25827527

7

Sentinel lymph node biopsy remains the most accurate method of obtaining staging and prognostic information for patients with primary cutaneous melanomas.

Friedman EB, Moncrieff MD, Lo S, Scolyer RA, Thompson JF. Friedman EB, et al. Among authors: scolyer ra. Australas J Dermatol. 2019 Feb;60(1):75-76. doi: 10.1111/ajd.12942. Epub 2018 Oct 7. Australas J Dermatol. 2019. PMID: 30294907 No abstract available.

8

The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.

Guitera P, Collgros H, Madronio CM, Goumas C, Mann GJ, Watts CG, Pereira AR, Armstrong BK, Drummond M, Morton RL, Scolyer RA, Menzies SW, Thompson JF, Cust AE. Guitera P, et al. Among authors: scolyer ra. Australas J Dermatol. 2019 May;60(2):118-125. doi: 10.1111/ajd.12928. Epub 2018 Oct 9. Australas J Dermatol. 2019. PMID: 30302753

9

Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study.

Smith AL, Watts CG, Robinson S, Schmid H, Goumas C, Mar VJ, Thompson JF, Rapport F; Australian Melanoma Centre of Research Excellence Study Group; Cust AE. Smith AL, et al. Australas J Dermatol. 2021 May;62(2):168-176. doi: 10.1111/ajd.13518. Epub 2020 Dec 5. Australas J Dermatol. 2021. PMID: 33277693

10

Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.

Paver EC, Cooper WA, Colebatch AJ, Ferguson PM, Hill SK, Lum T, Shin JS, O'Toole S, Anderson L, Scolyer RA, Gupta R. Paver EC, et al. Among authors: scolyer ra. Pathology. 2021 Feb;53(2):141-156. doi: 10.1016/j.pathol.2020.10.007. Epub 2020 Dec 30. Pathology. 2021. PMID: 33388161 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

789 results

Search Page